Tod M. Woolf

2.0k total citations · 1 hit paper
18 papers, 1.7k citations indexed

About

Tod M. Woolf is a scholar working on Molecular Biology, Genetics and Developmental Neuroscience. According to data from OpenAlex, Tod M. Woolf has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Developmental Neuroscience. Recurrent topics in Tod M. Woolf's work include RNA and protein synthesis mechanisms (6 papers), DNA and Nucleic Acid Chemistry (5 papers) and RNA Interference and Gene Delivery (5 papers). Tod M. Woolf is often cited by papers focused on RNA and protein synthesis mechanisms (6 papers), DNA and Nucleic Acid Chemistry (5 papers) and RNA Interference and Gene Delivery (5 papers). Tod M. Woolf collaborates with scholars based in United States and Indonesia. Tod M. Woolf's co-authors include D. A. Melton, Charles Jennings, Gerald H. Thomsen, Joan Vaughan, Wylie Vale, Malcolm Whitman, Sergei Y. Sokol, Douglas A. Melton, Kevin Pang and David Bumcrot and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Tod M. Woolf

18 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures

1990 535 citations Gerald H. Thomsen, Tod M. Woolf et al. Cell profile →

Peers

Countries citing papers authored by Tod M. Woolf

Since Specialization

Citations

This map shows the geographic impact of Tod M. Woolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tod M. Woolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tod M. Woolf more than expected).

Fields of papers citing papers by Tod M. Woolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tod M. Woolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tod M. Woolf. The network helps show where Tod M. Woolf may publish in the future.

Co-authorship network of co-authors of Tod M. Woolf

This figure shows the co-authorship network connecting the top 25 collaborators of Tod M. Woolf. A scholar is included among the top collaborators of Tod M. Woolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tod M. Woolf. Tod M. Woolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	To cleave or not to cleave: therapeutic gene editing with and without programmable nucleases 2017 ·Nature Reviews Drug Discovery ·Tod M. Woolf, Channabasavaiah B. Gurumurthy, Frederick M. Boyce, Eric B. Kmiec	8
2	Potent and systematic RNAi mediated silencing with single oligonucleotide compounds 2011 ·RNA ·(unknown), William E. Salomon, James Cardia, (unknown), (unknown), (unknown), (unknown), (unknown), Tod M. Woolf, Joanne Kamens, Anastasia Khvorova, Dmitry Samarsky	7
3	Modified dsRNAs that are not processed by Dicer maintain potency and are incorporated into the RISC 2010 ·Nucleic Acids Research ·William E. Salomon, (unknown), (unknown), P A Pavco, Tod M. Woolf, Joanne Kamens	23
4	Therapeutic repair of mutated nucleic acid sequences 1998 ·Nature Biotechnology ·Tod M. Woolf	29
5	Variations on the theme of genomics 1998 ·Trends in Genetics ·Tod M. Woolf	3
6	Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult In vitro. 1997 ·PubMed ·(unknown), H. Wang, Jörg A. Ott, Josephine D’Alessandro, Tod M. Woolf, David Bumcrot, Nagesh K. Mahanthappa, Kevin Pang	115
7	Sonic Hedgehog Promotes the Survival of Specific CNS Neuron Populations and Protects These Cells from Toxic InsultIn Vitro 1997 ·Journal of Neuroscience ·(unknown), (unknown), (unknown), Josephine D’Alessandro, Tod M. Woolf, David Bumcrot, Nagesh K. Mahanthappa, Kevin Pang	106
8	Optimizing the Cell Efficacy of Synthetic Ribozymes 1996 ·Journal of Biological Chemistry ·Thale C. Jarvis, Francine E. Wincott, L. J. Alby, James A. McSwiggen, Leonid Beigelman, (unknown), Anthony B. DiRenzo, (unknown), (unknown), Jasenka Matulić‐Adamić, Alexander Karpeisky, Carolyn Gonzalez, Tod M. Woolf, Nassim Usman, Dan T. Stinchcomb	63
9	Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein 1995 ·Nature Medicine ·Monica Z. Wang, (unknown), David Bumcrot, Valeria Marigo, Andrew P. McMahon, Elizabeth A. Wang, Tod M. Woolf, Kevin Pang	141
10	To Cleave or Not To Cleave: Ribozymes and Antisense 1995 ·PubMed ·Tod M. Woolf	21
11	Toward the therapeutic editing of mutated RNA sequences. 1995 ·Proceedings of the National Academy of Sciences ·Tod M. Woolf, (unknown), Dan T. Stinchcomb	79
12	Antisense oligonucleotides as antiviral agents: prospects and problems 1993 ·Trends in Microbiology ·Edouard M. Cantin, Tod M. Woolf	7
13	Expression of Activin mRNA during Early Development in Xenopus laevis 1993 ·Developmental Biology ·Cord Dohrmann, Ali Hemmati‐Brivanlou, Gerald H. Thomsen, Andrew T. Fields, Tod M. Woolf, Douglas A. Melton	85
14	Specificity of antisense oligonucleotides in vivo. 1992 ·Proceedings of the National Academy of Sciences ·Tod M. Woolf, D. A. Melton, Charles Jennings	209
15	Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures breakdown → 1990 ·Cell ·Gerald H. Thomsen, Tod M. Woolf, Malcolm Whitman, Sergei Y. Sokol, Joan Vaughan, Wylie Vale, D. A. Melton	535
16	The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos 1990 ·Nucleic Acids Research ·Tod M. Woolf, Charles Jennings, Michael R. Rebagliati, Douglas A. Melton	141
17	Oligodeoxynucleotides: Antisense inhibitors of gene expression 1990 ·Trends in Biochemical Sciences ·Tod M. Woolf	105
18	Mapping genomic organization by field inversion and two-dimensional gel electrophoresis: application to the murine T-cell receptor γ gene family 1988 ·Nucleic Acids Research ·Tod M. Woolf, Eric Lai, (unknown), L Hood	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact